CymitQuimica logo

Nicotinamide-beta-D-riboside H-L-tartrate

CAS:

Ref. 3D-NN175225

1g
To inquire
2g
To inquire
100mg
To inquire
250mg
To inquire
500mg
To inquire
Nicotinamide-beta-D-riboside H-L-tartrate
Biosynth

    Product Information

    Name:Nicotinamide-beta-D-riboside H-L-tartrate
    Synonyms:
    • 3-Carbamoyl-1-(beta-D-ribofuranosyl)-pyridinium 2,3-dihydroxybutanedioate (2S) (1:1)
    Brand:Biosynth
    Description:Nicotinamide riboside hydrogen tartrate or NR hydrogen tartrate, as well as a nicotinamide riboside hydrogen malate, is a nicotinamide riboside (NR) acidic salt used as a precursor for NAD+. This co-enzyme, NAD+, is a key player in the cell metabollism to avoid aging and neurodegerative diseases, as well as helping in the conversion of nutrients into energy. As an oral supplement, nicotinamide riboside hydrogen tartrate can boost the levels of NAD+ and contribute to the proper functioning of mitochondrial metabolism. Furthermore, recent studies carried out suggest that extra supplementation of NAD+ accelerates recovery from COVID-19 and supports immunity to SARS-CoV-2.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:404.33 g/mol
    Formula:C15H20N2O11
    Purity:Min. 95%

    Technical inquiry about: Nicotinamide-beta-D-riboside H-L-tartrate

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.